138 related articles for article (PubMed ID: 36208587)
1. Modelling fatty liver disease with mouse liver-derived multicellular spheroids.
van Os EA; Cools L; Eysackers N; Szafranska K; Smout A; Verhulst S; Reynaert H; McCourt P; Mannaerts I; van Grunsven LA
Biomaterials; 2022 Nov; 290():121817. PubMed ID: 36208587
[TBL] [Abstract][Full Text] [Related]
2. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
[TBL] [Abstract][Full Text] [Related]
3. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and Fibrosis.
Pingitore P; Sasidharan K; Ekstrand M; Prill S; Lindén D; Romeo S
Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30986904
[TBL] [Abstract][Full Text] [Related]
4. The fibrotic response of primary liver spheroids recapitulates in vivo hepatic stellate cell activation.
Mannaerts I; Eysackers N; Anne van Os E; Verhulst S; Roosens T; Smout A; Hierlemann A; Frey O; Leite SB; van Grunsven LA
Biomaterials; 2020 Dec; 261():120335. PubMed ID: 32891040
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered Multicellular Liver Microtissues for Modeling Advanced Hepatic Fibrosis Driven Through Non-Alcoholic Fatty Liver Disease.
Cho HJ; Kim HJ; Lee K; Lasli S; Ung A; Hoffman T; Nasiri R; Bandaru P; Ahadian S; Dokmeci MR; Lee J; Khademhosseini A
Small; 2021 Apr; 17(14):e2007425. PubMed ID: 33690979
[TBL] [Abstract][Full Text] [Related]
6. Cooperation of liver cells in health and disease.
Kmieć Z
Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
[TBL] [Abstract][Full Text] [Related]
7. The role of sinusoidal endothelial cells and TIMP1 in the regulation of fibrosis in a novel human liver 3D NASH model.
van Riet S; Julien A; Atanasov A; Nordling Å; Ingelman-Sundberg M
Hepatol Commun; 2024 Mar; 8(3):. PubMed ID: 38358377
[TBL] [Abstract][Full Text] [Related]
8. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Li BH; He FP; Yang X; Chen YW; Fan JG
Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
[TBL] [Abstract][Full Text] [Related]
9. Human Liver Spheroids as a Model to Study Aetiology and Treatment of Hepatic Fibrosis.
Hurrell T; Kastrinou-Lampou V; Fardellas A; Hendriks DFG; Nordling Å; Johansson I; Baze A; Parmentier C; Richert L; Ingelman-Sundberg M
Cells; 2020 Apr; 9(4):. PubMed ID: 32295224
[TBL] [Abstract][Full Text] [Related]
10. Role of G Protein-Coupled Receptors in Hepatic Stellate Cells and Approaches to Anti-Fibrotic Treatment of Non-Alcoholic Fatty Liver Disease.
Kimura T; Singh S; Tanaka N; Umemura T
Front Endocrinol (Lausanne); 2021; 12():773432. PubMed ID: 34938271
[TBL] [Abstract][Full Text] [Related]
11. Extracellular vesicles derived from fat-laden hepatocytes undergoing chemical hypoxia promote a pro-fibrotic phenotype in hepatic stellate cells.
Hernández A; Reyes D; Geng Y; Arab JP; Cabrera D; Sepulveda R; Solis N; Buist-Homan M; Arrese M; Moshage H
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165857. PubMed ID: 32512191
[TBL] [Abstract][Full Text] [Related]
12. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis.
Tølbøl KS; Kristiansen MN; Hansen HH; Veidal SS; Rigbolt KT; Gillum MP; Jelsing J; Vrang N; Feigh M
World J Gastroenterol; 2018 Jan; 24(2):179-194. PubMed ID: 29375204
[TBL] [Abstract][Full Text] [Related]
13. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation.
Bates J; Vijayakumar A; Ghoshal S; Marchand B; Yi S; Kornyeyev D; Zagorska A; Hollenback D; Walker K; Liu K; Pendem S; Newstrom D; Brockett R; Mikaelian I; Kusam S; Ramirez R; Lopez D; Li L; Fuchs BC; Breckenridge DG
J Hepatol; 2020 Oct; 73(4):896-905. PubMed ID: 32376414
[TBL] [Abstract][Full Text] [Related]
14. Pathophysiological communication between hepatocytes and non-parenchymal cells in liver injury from NAFLD to liver fibrosis.
Kumar S; Duan Q; Wu R; Harris EN; Su Q
Adv Drug Deliv Rev; 2021 Sep; 176():113869. PubMed ID: 34280515
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Human Liver Model of Nonalcoholic Steatohepatitis by Coculturing Hepatocytes, Endothelial Cells, and Kupffer Cells.
Suurmond CE; Lasli S; van den Dolder FW; Ung A; Kim HJ; Bandaru P; Lee K; Cho HJ; Ahadian S; Ashammakhi N; Dokmeci MR; Lee J; Khademhosseini A
Adv Healthc Mater; 2019 Dec; 8(24):e1901379. PubMed ID: 31746151
[TBL] [Abstract][Full Text] [Related]
16. Generation and Culture of Primary Mouse Hepatocyte-Hepatic Stellate Cell Spheroids.
Mannaerts I; Eysackers N; van Grunsven LA
Methods Mol Biol; 2023; 2669():193-206. PubMed ID: 37247061
[TBL] [Abstract][Full Text] [Related]
17. Non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention.
Tacke F; Weiskirchen R
Ann Transl Med; 2021 Apr; 9(8):729. PubMed ID: 33987427
[TBL] [Abstract][Full Text] [Related]
18. Activin-A causes Hepatic stellate cell activation via the induction of TNFα and TGFβ in Kupffer cells.
Kiagiadaki F; Kampa M; Voumvouraki A; Castanas E; Kouroumalis E; Notas G
Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):891-899. PubMed ID: 29287776
[TBL] [Abstract][Full Text] [Related]
19. Enhanced expression of BMP6 inhibits hepatic fibrosis in non-alcoholic fatty liver disease.
Arndt S; Wacker E; Dorn C; Koch A; Saugspier M; Thasler WE; Hartmann A; Bosserhoff AK; Hellerbrand C
Gut; 2015 Jun; 64(6):973-81. PubMed ID: 25011936
[TBL] [Abstract][Full Text] [Related]
20. Metabolic inflammation as an instigator of fibrosis during non-alcoholic fatty liver disease.
Katsarou A; Moustakas II; Pyrina I; Lembessis P; Koutsilieris M; Chatzigeorgiou A
World J Gastroenterol; 2020 May; 26(17):1993-2011. PubMed ID: 32536770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
